These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 27626445

  • 1. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
    Wang H, Yu R, Fang T, Yu T, Chi X, Zhang X, Liu S, Fu L, Yu C, Chen W.
    Toxins (Basel); 2016 Sep 11; 8(9):. PubMed ID: 27626445
    [Abstract] [Full Text] [Related]

  • 2. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S, Seifi-Najmi M, Ghasemi B, Kafil HS, Alinejad V, Sadreddini S, Younesi V, Jadidi-Niaragh F, Yousefi M.
    Hum Antibodies; 2015 Dec 23; 23(3-4):73-9. PubMed ID: 27472865
    [Abstract] [Full Text] [Related]

  • 3. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
    Indrawattana N, Sookrung N, Kulkeaw K, Seesuay W, Kongngoen T, Chongsa-nguan M, Tungtrongchitr A, Chaicumpa W.
    Asian Pac J Allergy Immunol; 2010 Mar 23; 28(1):85-93. PubMed ID: 20527521
    [Abstract] [Full Text] [Related]

  • 4. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
    Yu R, Wang S, Yu YZ, Du WS, Yang F, Yu WY, Sun ZW.
    J Biomol Screen; 2009 Sep 23; 14(8):991-8. PubMed ID: 19726786
    [Abstract] [Full Text] [Related]

  • 5. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
    Li Y, Chen Y, Cui J, Liu D, Zhang W, Xue C, Xiong X, Liu G, Chen H.
    J Immunol Methods; 2023 Feb 23; 513():113427. PubMed ID: 36652969
    [Abstract] [Full Text] [Related]

  • 6. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
    Yousefi M, Tahmasebi F, Younesi V, Razavi A, Khoshnoodi J, Bayat AA, Abbasi E, Rabbani H, Jeddi-Tehrani M, Shokri F.
    J Immunotoxicol; 2014 Feb 23; 11(1):28-34. PubMed ID: 23369087
    [Abstract] [Full Text] [Related]

  • 7. Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.
    Cheng K, Lu J, Guo J, Wang R, Chen L, Wang X, Jiang Y, Li Y, Xu C, Kang Q, Qiaerxie G, Du P, Gao C, Yu Y, Yang Z, Wang W.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2366641. PubMed ID: 38934499
    [Abstract] [Full Text] [Related]

  • 8. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
    Minamitani T, Kiyose K, Otsubo R, Ito T, Akiba H, Furuta RA, Inoue T, Tsumoto K, Satake M, Yasui T.
    Sci Rep; 2021 Jun 09; 11(1):12134. PubMed ID: 34108521
    [Abstract] [Full Text] [Related]

  • 9. Production of Recombinant Human scFv Against Tetanus Toxin Heavy Chain by Phage Display Technology.
    Khalili E, Lakzaei M, Rasaee MJ, Aminian M.
    Monoclon Antib Immunodiagn Immunother; 2015 Oct 09; 34(5):303-9. PubMed ID: 26492617
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
    Liu XY, Wei DK, Li ZY, Lu JS, Xie XM, Yu YZ, Pang XB.
    Vaccine; 2023 Nov 02; 41(46):6834-6841. PubMed ID: 37816654
    [Abstract] [Full Text] [Related]

  • 11. Comparative human and mouse antibody responses against tetanus toxin at clonal level.
    Yousefi M, Younesi V, Bayat AA, Jadidi-Niaragh F, Abbasi E, Razavi A, Khosravi-Eghbal R, Asgarian-Omran H, Shokri F.
    J Immunotoxicol; 2016 Nov 02; 13(2):243-8. PubMed ID: 25990600
    [Abstract] [Full Text] [Related]

  • 12. Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice.
    Zhang G, Yu R, Chi X, Chen Z, Hao M, Du P, Fan P, Liu Y, Dong Y, Fang T, Chen Y, Song X, Liu S, Li J, Yu C, Chen W.
    Int Immunopharmacol; 2021 Feb 02; 91():107297. PubMed ID: 33360088
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
    Yu R, Hou L, Yu C, Liu S, Ren J, Fang T, Zhang X, Chen W.
    Immunobiology; 2011 Apr 02; 216(4):485-90. PubMed ID: 20888666
    [Abstract] [Full Text] [Related]

  • 14. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD, Wu YY, Tsai YJ, Tsai YS, Lin YY, Lai SL, Huang CY, Lok YY, Hu CY, Lai JS.
    Int J Mol Sci; 2016 Feb 05; 17(2):214. PubMed ID: 26861297
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing anti-diphtheria toxin scFv produced by phage display.
    Khalili E, Lakzaei M, Aminian M.
    Biotechnol Lett; 2024 Jun 05; 46(3):385-398. PubMed ID: 38607601
    [Abstract] [Full Text] [Related]

  • 16. Structural basis of tetanus toxin neutralization by native human monoclonal antibodies.
    Wang Y, Wu C, Yu J, Lin S, Liu T, Zan L, Li N, Hong P, Wang X, Jia Z, Li J, Wang Y, Zhang M, Yuan X, Li C, Xu W, Zheng W, Wang X, Liao HX.
    Cell Rep; 2021 May 04; 35(5):109070. PubMed ID: 33951441
    [Abstract] [Full Text] [Related]

  • 17. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ, Liu S, Ma Y, Gong ZW, Wang S, Sun ZW.
    Hum Vaccin Immunother; 2014 May 04; 10(7):1874-9. PubMed ID: 25424795
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.
    Yousefi M, Khosravi-Eghbal R, Reza Mahmoudi A, Jeddi-Tehrani M, Rabbani H, Shokri F.
    Hum Vaccin Immunother; 2014 May 04; 10(2):344-51. PubMed ID: 24126015
    [Abstract] [Full Text] [Related]

  • 19. Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction.
    Lukić I, Marinković E, Filipović A, Krnjaja O, Kosanović D, Inić-Kanada A, Stojanović M.
    Toxicon; 2015 Sep 04; 103():135-44. PubMed ID: 26140841
    [Abstract] [Full Text] [Related]

  • 20. The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.
    Yu R, Ji C, Xu J, Wang D, Fang T, Jing Y, Kwang-Fu Shen C, Chen W.
    Biomed Res Int; 2018 Sep 04; 2018():6057348. PubMed ID: 30687751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.